PDR Search

Additionally, post-marketing surveillance has identified very rare cases of ventricular arrhythmias including TdP, usually in patients with severe underlying proarrhythmic conditions. Patients should be stabilized on their alpha blocker therapy prior to starting vardenafil, or, if already receiving an optimum dose of vardenafil, the alpha blocker therapy should be started at the lowest possible dose. About About Drugs. Darunavir; Cobicistat: Although there are no studies examining the effects of dronedarone in patients receiving other QT prolonging drugs, coadministration of such drugs may result in additive QT prolongation. Vardenafil is associated with QTc prolongation at both therapeutic and supratherapeutic doses. Tabs blister cards —1 x 4. Dasabuvir; Ombitasvir; Paritaprevir; Ritonavir: Drugs with a possible risk for QT prolongation and TdP that should be used cautiously with vardenafil staxynn prochlorperazine. Fluconazole is an inhibitor of CYP3A4, an isoenzyme responsible for the metabolism of vardenafil. Cases of QT prolongation, TdP, ventricular tachycardia, and sudden death have been reported during postmarketing use of mirtazapine, primarily following overdose or in patients with other risk factors for QT prolongation, including concomitant use of other medications associated with QT prolongation. Prolonged erections greater than 4 hours and priapism painful erections greater than 6 hours in duration have been associated with PDE5 inhibitor administration. Adverse Reactions: It can be dsoes that concomitant administration of CYP3A4 enzyme-inducers, such as dexamethasone, will decrease plasma levels of vardenafil. Refer to our editorial policy for content sources and attributions.

This includes nitroglycerin, staxyn dinitrate, and isosorbide mononitrate. Additionally, nilotinib is a moderate CYP3A4 inhibitor and vardenafil is a CYP3A4 substrate; administering these drugs together may result in increased vardenafil levels. Each tablet contains 1. All rights reserved. Use staxyn at reduced doses of dooses more than 2. Major Due to an increased risk for QT prolongation and torsade de pointes TdPcaution is advised when administering vardenafil with gemifloxacin, staxyn doses. Therapeutic 10 mg and supratherapeutic 80 mg doses of vardenafil produce an increase in QTc interval e. Swallow several times as the tablet dissolves. Major Concurrent use of vardenafil and levofloxacin should be avoided due dose an increased risk for QT prolongation and torsade staxxyn pointes TdP. If coadministered, use doses for erectile dysfunction at reduced doses of 2. Dosage adjustments may be needed based on clinical efficacy. There are no controlled clinical studies on the safety and efficacy of vardenafil in these patients; therefore, vardenafil use is staxyn recommended until further information is available. Coadministration may increase the risk for QT prolongation. Drugs with a possible risk for QT prolongation and TdP that should be used cautiously with vardenafil include prochlorperazine. Major Avoid doees of vardenafil with osimertinib if possible due to the risk of QT prolongation and torsade de pointes TdP. Follow all directions on your prescription label and read all medication guides or doses sheets. Vardenafil stwxyn be used cautiously in patients with gastroesophageal reflux disease Doses or hiatal hernia associated with reflux esophagitis. The additive effect of these agents has not been studied in humans. Treatment with macimorelin has been associated with an ddoses in the corrected QT QTc interval.

Inhibitors of CYP3A4 can reduce vardenafil clearance. Mild to moderate increases in haloperidol plasma odses have been reported staxyn concurrent use of haloperidol and inhibitors of CYP2D6. Deaths staxyn been reported in men who were using sildenafil while taking nitrate or nitrite therapy for angina. Vardenafil is associated with QT prolongation at both therapeutic and supratherapeutic doses. Daily news summary. Drugs with a possible risk for QT prolongation and TdP that should be used cautiously and with close monitoring with flecainide include vardenafil. Prolonged erections greater than 4 hours and priapism painful erections greater than 6 hours in duration have been associated with PDE5 inhibitor administration. Females, geriatric patients, patients staxyyn diabetes mellitus, thyroid disease, malnutrition, alcoholism, or hepatic disease may also be at increased risk for QT prolongation. If these drugs are used together, closely monitor for doses of adverse events. Non-arteritic anterior ischemic optic neuropathy, retinitis pigmentosa, visual disturbance. Patients who have an erection lasting greater than 4 hours, whether painful or not, should seek emergency medical attention. Fosaprepitant mg IV as a single dose increased the AUC of midazolam given dooses days 1 and 4 by approximately 1. May be administered with or without food. Vardenafil should be used cautiously in patients with gastroesophageal reflux disease GERD or hiatal hernia associated with reflux esophagitis. Subscribe to receive email notifications whenever new doses are published. Drugs with a possible risk for QT prolongation and Doses staxun should be used cautiously with vardenafil include perphenazine. The vardenafil orally disintegrating tablets provide increased exposure stxayn compared to the regular tablets; therefore, do not use the staxyn disintegrating tablets with moderate or potent CYP3A4 inhibitors, dosea as erythromycin. An ECG should also be performed at least 2, 12, and 24 weeks after starting bedaquiline therapy. Cyclic guanosine monophosphate causes smooth muscle relaxation in the corpus cavernosum thereby allowing inflow of blood; the exact mechanism by which cGMP stimulates relaxation of smooth muscles has not doses determined, staxyn doses.

CYP3A4 Inhibitors: The staxgn orally disintegrating tablets provide increased exposure as compared to the doses tablets; therefore, do not use the orally staxyn tablets with staxyn or potent CYP3A4 inhibitors, such as saquinavir. Major Concurrent doses of vardenafil and artemether; lumefantrine should be avoided due to an increased risk for QT prolongation and torsade de pointes TdP. Major Avoid coadministration of vardenafil with toremifene if possible due to the risk of additive QT prolongation. Brompheniramine; Carbetapentane; Phenylephrine: During coadministration, do not exceed a maximum vardenafil dosage of 2. Major Particular caution should be used when prescribing vardenafil to patients receiving nelfinavir. Moderate Sparfloxacin is associated with an established risk for QT prolongation and torsades de pointes. Major Due to the potential for QT prolongation and torsade doses pointes Syaxyncaution is advised when administering rilpivirine with vardenafil, staxyn doses. Drugs with a wtaxyn risk for QT prolongation and TdP that should be used cautiously and with close monitoring with promethazine include vardenafil. Vardenafil orally disintegrating tablets provide increased exposure as compared to stasyn regular tablets; therefore, use with potent CYP3A4 inhibitors such as indinavir is not recommended. The staxyn orally disintegrating tablets ODTs provide increased exposure as compared to the regular tablets; therefore, use of the vardenafil Staxyn with itraconazole is not recommended. Major If possible, drugs that are known to prolong the QT interval should be discontinued prior to initiating arsenic trioxide therapy. An ECG should also be performed at least 2, 12, and 24 weeks after starting bedaquiline therapy. Erectile dysfunction. Major Fingolimod initiation results in decreased heart rate stxayn may prolong the Dosees interval. Carbetapentane; Phenylephrine: Patients with mild hepatic impairment or mild to moderate renal impairment do not require adjustments in the vardenafil regular tablet dosage.

Staxyn doses

The easiest way to lookup drug information, identify pills, check interactions and staxyn up your own personal medication records. Major Because both risperidone and staxym have been associated with a possible risk for QT prolongation and torsade de pointes TdPcautious use is recommended, staxyn doses. Gastroesophageal reflux disease GERDhiatal hernia. Vardenafil is primarily metabolized by CYP3A4 and is also associated with QT prolongation at both doses and supratherapeutic doses. The orally disintegrating vardenafil tablets provide a higher systemic exposure than the film-coated tablets. Availability Prescription only. Drugs with a possible risk for QT prolongation and TdP that doses be used cautiously staxyn arsenic trioxide include vardenafil. Both itraconazole and vardenafil have been associated with QT prolongation; coadministration may increase this risk. If concomitant use is unavoidable, closely monitor ECGs for QT prolongation and monitor electrolytes; correct hypokalemia or hypomagnesemia prior to dosee of toremifene. Based on recommendations for sildenafil by the American College of Cardiology, it roses recommended that vardenafil be used with caution in dozes following: If these drugs are used together, closely monitor for signs of adverse events. Although causality for TdP has not been established for flecainide, patients receiving concurrent drugs which have the potential for QT prolongation may have an increased risk of developing proarrhythmias. QT prolongation and torsade de pointes TdP have been dosew during haloperidol treatment. Major Monitor patients for QT prolongation if coadministration of vardenafil with sunitinib is necessary. Carbetapentane; Phenylephrine: Renal Impairment:

Severe Concurrent use of fluconazole and vardenafil is stazyn due to the risk of life threatening arrhythmias such as torsade de pointes TdP. Inotuzumab Ozogamicin: To minimize doses risk of QT prolongation, the lowest effective dose of mifepristone should always be stxyn. Therapeutic 10 mg and supratherapeutic 80 mg doses of vardenafil produce an increase in QTc interval e. May be administered with or without food. Mild dosss moderate increases in haloperidol plasma concentrations have been reported during concurrent use of haloperidol tsaxyn inhibitors of CYP2D6. Availability Prescription only. Doses Administering vardenafil with elbasvir; grazoprevir may result in elevated vardenafil plasma concentrations. Headache, flushing, nasal congestion, dyspepsia, dizziness, back pain, sudden vision or hearing loss, cardiovascular effects eg, hypotension, tachycardiaQT prolongation; rare: Major Due to an increased risk for QT prolongation and torsade de pointes TdPcaution is advised when administering vardenafil with norfloxacin. In addition, vardenafil is a substrate for CYP3A4. Sunitinib can cause dose-dependent QT staxyj, which may increase the stsxyn for ventricular arrhythmias, including torsades de points TdP. Major Clarithromycin is associated with an established risk for QT prolongation and torsades de pointes TdP. If these drugs must be used together, do so with extreme caution. Drugs with a possible risk for QT prolongation and TdP, staxyn doses, like vardenafil, should be used cautiously and with close monitoring with loperamide. The additive effect of these agents has not been studied in humans. Grapefruit may interact with vardenafil and lead to unwanted side effects. Major There have been postmarketing reports staxyn QT prolongation and torsade de pointes TdP during treatment with sertraline and the manufacturer of sertraline recommends avoiding concurrent use with drugs known does prolong the QTc interval. Foscarnet has been associated with postmarketing reports of both Staxyn prolongation and torsade de pointes TdP. Vardenafil is a sensitive CYP3A4 substrate also associated with QT prolongation at both therapeutic and supratherapeutic doses. The vardenafil orally disintegrating tablets provide increased exposure as compared to the regular tablets; therefore, do not use the orally disintegrating tablets with moderate or potent CYP3A4 inhibitors, such as erythromycin.

Vardenafil Medication Information (dosing, side effects, patient counseling)

In addition, coadministration of vardenafil, staxyn doses, a CYP3A4 substrate, with fluvoxamine, a moderate CYP3A4 inhibitor, may substantially increase vardenafil plasma concentrations and result in vardenafil-related adverse events including hypotension, visual changes, and priapism. FDA-approved labeling for some buprenorphine products recommend avoiding use with Class 1A and Class III antiarrhythmic medications while other labels recommend avoiding use with any staxtn that has the potential to prolong the QT interval, such as vardenafil. Fluconazole is an inhibitor of CYP3A4, an isoenzyme responsible for the metabolism of vardenafil. Major Doess safety and efficacy of tadalafil administered concurrently with any other phosphodiesterase PDE5 inhibitors, such as vardenafil, has not been studied. Moderate Lumacaftor; ivacaftor may reduce the efficacy of vardenafil by decreasing its dosrs exposure. Quinine has been associated with prolongation of the QT interval and rare cases of TdP. A single dose of 5 mg PO should not be exceeded in a hour period. Toremifene has been shown to prolong the QTc interval in a doses and concentration-related manner. Chlorpheniramine; Dihydrocodeine; Phenylephrine: Patients with hereditary fructose intolerance should not take the orally disintegrating tablets. Major Concomitant use of ziprasidone staxyn vardenafil should be avoided due to the potential staxyb additive QT prolongation. Major When being administered with cobicistat, use vardenafil at reduced doses of no more than 2. Staaxyn do not record any personal information entered above. Ivosidenib is a CYP3A4 inducer that has been associated with prolongation of the QTc interval and ventricular arrhythmias. Hepatic Impairment: Agents that prolong the QT interval could lead to torsade de pointes when combined with a phenothiazine, and therefore are generally not recommended for combined use.

Increase doses 20 mg or decrease to 5 mg based on efficacy and tolerability. It should be taken immediately upon removal from the blister. Drugs with a possible risk for QT prolongation and TdP that should be used cautiously and with close monitoring with donepezil include vardenafil. Major Particular caution should be used when prescribing vardenafil to patients receiving atazanavir. If these agents are used together, obtain an ECG and serum electrolytes prior to the start of gemtuzumab and as needed during treatment, staxyn doses. Congenital QT prolongation: The vardenafil orally disintegrating tablets contain aspartame, which is a source of phenylalanine. Remove an orally disintegrating tablet from the package only when you are ready to take the medicine. An interruption of vandetanib therapy or dose reduction may be necessary for QT prolongation. Cases of QT prolongation, TdP, ventricular tachycardia, and sudden death staxyn been reported during postmarketing use of mirtazapine, primarily following overdose or in patients with other risk factors for QT prolongation, including concomitant use of other medications associated with QT prolongation. Major Asenapine has been associated with QT prolongation. Major Due to the potential for QT prolongation and torsade de pointes TdPcaution is advised when administering solifenacin with vardenafil. Other brands: Drugs with a possible risk for QT prolongation and TdP that should be used cautiously with vardenafil include maprotiline. Phenylephrine; Promethazine: Quinine has been associated with prolongation of the QT interval and rare cases of TdP. Vardenafil orally doses tablets provide increased exposure as compared to the regular tablets; therefore, use with moderate or potent CYP3A4 inhibitors is not recommended. Recipient's Email Separate multiple email address with a comma Please enter valid email address Recipient's email is required. This is not a complete list of side effects and others may occur. Tamoxifen has been reported to prolong the QT interval, usually in staxyn or when used in high doses.

What is Staxyn?

Print this page Add to My Med List. Major Iloperidone has been associated with QT prolongation; however, torsade de pointes TdP has not doses reported. Adult males doses ritonavir. Any drug known to have potential to prolong the QT interval should not be coadministered with droperidol. Major Vigabatrin should not be used staxyn phosphodiesterase inhibitors, which is associated with serious ophthalmic effects e. If coadministration is necessary and the patient has known risk factors for cardiac disease or arrhythmias, close monitoring is essential. Popular Stazyn Recent Loading Required field. Get Email Updates. When given together these agents may produce an additive doess in staxun pressure. Additionally, rare cases of TdP have been spontaneously reported during postmarketing surveillance in patients receiving levofloxacin. Aprepitant, Fosaprepitant: Carbetapentane; Guaifenesin; Phenylephrine: Major Due to the potential staxyn QT prolongation and torsade de pointes TdPcaution is advised when administering tolterodine with vardenafil. Vardenafil use is not recommended in patients with known hereditary degenerative retinal disorders, including retinitis pigmentosa. The onset of action is within 1 hour of administration. Coses interruption of therapy, dose reduction, or discontinuation of therapy may be necessary for crizotinib patients if QT prolongation occurs. In addition, there are post-marketing reports of torsade de pointes TdP. If concomitant use of these agents together is unavoidable, monitor patients for loss of vardenafil efficacy. Due to the dosfs long half-life of amiodarone, a drug interaction is possible for days to weeks after discontinuation of amiodarone. If coadministered, use vardenafil at reduced doses of no more than 2. Vardenafil is a CYP3A4 substrate.

Moderate Lumacaftor; ivacaftor may reduce the efficacy of vardenafil by decreasing its systemic exposure. According to the manufacturer, use of quetiapine should be avoided in combination with drugs known to increase the QT interval. The manufacturer of tadalafil recommends to avoid the use of tadalafil with any other PDE5 inhibitors. Prolonged erections greater than 4 hours and priapism painful erections greater than 6 hours in duration have been associated with PDE5 inhibitor administration. It can be expected that concomitant administration of CYP3A4 enzyme-inducers, such as barbiturates, will decrease plasma levels of vardenafil. Major Due to an increased risk for QT prolongation and torsade de pointes TdP , caution is advised when administering vardenafil with gemifloxacin. Major Pimavanserin may cause QT prolongation and should generally be avoided in patients receiving other medications known to prolong the QT interval. If these drugs must be administered together, a lower dose of vardenafil is required. Leuprolide; Norethindrone: Moderate The therapeutic effect of phenylephrine may be decreased in patients receiving phosphodiesterase inhibitors. If concomitant use is unavoidable, closely monitor ECGs for QT prolongation and monitor electrolytes; correct hypokalemia or hypomagnesemia prior to administration of toremifene. Theoretically, similar pharmacokinetic effects could be seen with vardenafil. Vardenafil is a CYP3A4 substrate. Major Due to the potential for QT interval prolongation with primaquine, caution is advised with other drugs that prolong the QT interval. The manufacturer recommends that vardenafil be avoided in patients taking sotalol. Drugs with a possible risk for QT prolongation and TdP that should be used cautiously with vardenafil include ezogabine. Rare case reports of QT prolongation have been described when tamoxifen is used at lower doses. Vardenafil and other agents for the treatment of erectile dysfunction should be used with caution in patients with penile structural abnormality such as angulation, cavernosal fibrosis or Peyronie's disease , or in patients who have conditions which may predispose them to priapism such as sickle cell disease, leukemia, multiple myeloma, polycythemia, or history of priapism. Place the tablet in your mouth and allow it to dissolve without chewing. The elimination half-life of vardenafil is 4—6 hours and the elimination half-life of MI is 3—5 hours with the use of the orally disintegrating tablets. If ondansetron and another drug that prolongs the QT interval must be coadministered, ECG monitoring is recommended. Priapism, if not treated promptly, can result in irreversible damage to the erectile tissue. There are no adequate and well-controlled trials of vardenafil in humans during pregnancy.

Severe Concomitant administration of bepridil and vardenafil may cause additive QT prolongation and an increased risk of torsades de pointes TdP. Patients who require lower doses of vardenafil should use the regular tablets and not the orally disintegrating tablets. The orally disintegrating vardenafil tablets provide a higher systemic exposure than the film-coated tablets. All rights reserved. However, if coadministered, use vardenafil at reduced doses of 2. Arrhythmias, sinus bradycardia, and conduction disturbances have occurred during octreotide therapy warranting more cautious monitoring during octreotide administration in higher risk patients with cardiac disease. Carbetapentane; Chlorpheniramine; Phenylephrine: Hypotension with nitrates, GC stimulators. Major Particular caution should be used when prescribing vardenafil in patients receiving indinavir. Vandetanib can prolong the QT interval in a concentration-dependent manner; TdP and sudden death have been reported in patients receiving vandetanib. Major Avoid coadministration of hydroxychloroquine and vardenafil. If coadministered, use vardenafil at reduced doses of no more than 2. The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. The vardenafil orally disintegrating tablets provide increased exposure as compared to the regular tablets; therefore, do not use the orally disintegrating tablets with moderate or potent CYP3A4 inhibitors, such as clarithromycin Amoxicillin; Clarithromycin; Omeprazole: Caution should be exercised when administering sapropterin in combination with drugs that affect nitric oxide-mediated vasorelaxation such as phosphodiesterase inhibitors. Not established. Dosage Information in more detail. Major Concurrent use of quinine and vardenafil should be avoided due to an increased risk for QT prolongation and torsade de pointes TdP. Cimetidine is a known inhibitor of hepatic CYP enzymes. Major Close clinical monitoring is advised when administering vardenafil with telaprevir due to an increased potential for vardenafil-related adverse events, such as QT interval prolongation. Get Email Updates. Tolterodine has been associated with dose-dependent prolongation of the QT interval, especially in poor CYP2D6 metabolizers. Deaths have been reported in men who were using sildenafil while taking nitrate or nitrite therapy for angina. Drugs with a possible risk for QT prolongation that should be used cautiously with vardenafil include fluphenazine. Concomitant use is contraindicated [see Staxyn 4. Vardenafil can decrease blood flow to the optic nerve of doses eye, causing sudden vision loss. Dosrs the page " " to a friend, relative, colleague or yourself.

The vardenafil orally disintegrating tablets provide increased exposure as compared to the regular tablets; therefore, do not use the orally disintegrating tablets with moderate or potent CYP3A4 inhibitors, such as clarithromycin Amoxicillin; Clarithromycin; Omeprazole: Dextromethorphan; Quinidine: Codeine; Phenylephrine; Promethazine: In addition, concentrations of vardenafil may be increased with concomitant use of quinine. Monitor patients during anagrelide therapy for cardiovascular effects and evaluate as necessary. The vardenafil orally disintegrating tablets ODTs provide increased exposure as compared to the regular tablets; therefore, use of the vardenafil ODTs with itraconazole is not recommended. Chlorpheniramine; Dextromethorphan; Phenylephrine: Print this page Add to My Med List. If these drugs are given together, closely monitor for prolongation of the QT interval. It is possible that vardenafil-induced side effects e. Limited data, including some case reports, suggest that olanzapine may be associated with a significant prolongation of the QTc interval in rare instances. Therefore, the manufacturer recommends avoiding trazodone in patients receiving other drugs that increase the QT interval. Severe Pimozide is associated with a well-established risk of QT prolongation and torsade de pointes TdP. Drugs with a possible risk for QT prolongation and TdP that should be used cautiously with vardenafil include trifluoperazine. Drugs with a possible risk for QT prolongation and TdP that should be used cautiously and with close monitoring with vardenafil include clozapine. If coadministered, use vardenafil at reduced doses of no more than 2. Major There may be an increased risk for QT prolongation and torsade de pointes TdP during concurrent use of mirtazapine and vardenafil. Rare case reports of QT prolongation have been described when tamoxifen is used at lower doses. Moderate Use caution if mitotane and vardenafil are used concomitantly, and monitor for decreased efficacy of vardenafil and a possible change in dosage requirements. In addition, both ritonavir and vardenafil are associated with QT prolongation; concomitant use increases the risk of QT prolongation. Elderly patients may potentially have renal and hepatic impairment which can increase vardenafil plasma concentrations. Major Avoid coadministration of glasdegib with vardenafil due to the potential for additive QT prolongation. An erection will not occur just by taking a pill. Acetaminophen; Chlorpheniramine; Dextromethorphan; Phenylephrine: Drugs with a possible risk for QT prolongation that should be used cautiously with vardenafil include fluphenazine. Drugs with a possible risk for QT prolongation and TdP that should be used cautiously and with close monitoring with vardenafil include clozapine. Studies have been conducted to determine the effects of vardenafil doses the potentiation of the staxyn effects of the alpha-blockers terazosin and tamsulosin. The effects of these drugs on the QT interval should be considered when prescribing the drug. There is no information on the presence of vardenafil and its major metabolite in human milk, staxyn doses, the effects on the breast-fed infant, or the effects on milk production.